Early detection of melanoma, the most aggressive skin cancer, is critical because melanoma will spread rapidly throughout the body. Now, University of Missouri researchers are one step closer to melanoma cancer detection ...
Jan 5, 2012
0
0
The federal Food and Drug Administration has approved an incisionless form of brain surgery to treat advanced Parkinson's disease after successful testing at the University of Virginia School of Medicine and other sites.
Nov 17, 2021
0
13
Partner companies Eisai and Biogen recently announced promising clinical trial results for their new Alzheimer's drug lecanemab. Over 18 months, patients treated with lecanemab experienced slower symptom progression than ...
Oct 14, 2022
0
5
A serial inventor in Connecticut has come up with a portable MRI intended, like his other devices, to make health care more affordable and accessible.
Nov 27, 2019
1
10
The recent U.S. Food and Drug Administration (FDA) approval of a brain aneurysm device has opened the door for neurosurgeons at Jefferson Hospital for Neuroscience (JHN) to offer advanced treatment to patients suffering from ...
Apr 18, 2011
0
0
Patients in the United States who have the cornea-damaging disease keratoconus may soon be able to benefit from a new treatment that is already proving effective in Europe and other parts of the world. The treatment, called ...
Oct 24, 2011
0
0
A much-debated drug for Lou Gehrig's disease won U.S. approval Thursday, a long-sought victory for patients that is likely to renew questions about the scientific rigor behind government reviews of experimental medicines.
Sep 30, 2022
0
8
When the coronavirus pandemic first hit the U.S., sales of window coverings at Halcyon Shades quickly went dark. So the suburban St. Louis business did what hundreds of other small manufacturers did: It pivoted to make protective ...
Apr 11, 2022
0
21
In a milestone years in the making, a vaccine to prevent cholera, invented and developed by researchers at the University of Maryland School of Medicine's Center for Vaccine Development, was approved today by the U.S. Food ...
Jun 11, 2016
0
201
The U.S. Food and Drug Administration has approved Litfulo (ritlecitinib) for adults and adolescents aged 12 years and older with severe alopecia areata at a recommended dose of 50 mg. Approval of Litfulo was granted to Pfizer.
Jun 27, 2023
0
1
